Complications after Second Trimester Surgical and Medical Abortion

References

• LA Bartlett, CJ Berg, HB Shulman. Risk factors for legal induced abortion-related mortality in the United States. Obstetrics and Gynecology. 103(4): 2004; 729–737.
   PubMed Web of Science ®Google Scholar
• DA Grimes, KF Schulz, WJ Cates Jr. Prevention of uterine perforation during curettage abortion. Jounal of the American Medical Association. 251(16): 1984; 2108–2111.
   Web of Science ®Google Scholar
• S Lalitkumar, M Bygdeman, K Gemzell-Danielsson. Mid-trimester induced abortion: a review. Human Reproduction Update. 13(1): 2007; 37–52.
   PubMed Web of Science ®Google Scholar
• PW Ashok, A Templeton, PT Wagaarachchi. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception. 69(1): 2004; 51–58.
   PubMed Web of Science ®Google Scholar
• DA Grimes, JF Hulka, ME McCutchen. Midtrimester abortion by dilatation and evacuation versus intra-amniotic instillation of prostaglandin F2 alpha: a randomized clinical trial. American Journal of Obstetrics and Gynecology. 137: 1980; 785–790.
   PubMed Web of Science ®Google Scholar
• DA Grimes, MS Smith, AD Witham. Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial. BJOG. 111(2): 2004; 148–153.
   Web of Science ®Google Scholar
• Lohr PA, Hayes JL, Gemzell-Danielsson K. Surgical versus medical methods for second trimester induced abortion. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD006714. DOI: 10.1002/14651858.CD006714.pub2.
   Google Scholar
• AM Autry, EC Hayes, GF Jacobson. A comparison of medical induction and dilation and evacuation for second-trimester abortion. American Journal of Obstetrics and Gynecology. 187(2): 2002; 393–397.
   PubMed Web of Science ®Google Scholar
• WF Peterson, FN Berry, MR Grace. Second-trimester abortion by dilatation and evacuation: an analysis of 11,747 cases. Obstetrics and Gynecology. 62(2): 1983; 185–190.
   Web of Science ®Google Scholar
• FR Jacot, C Poulin, AP Bilodeau. A five-year experience with second-trimester induced abortions: no increase in complication rate as compared to the first trimester. American Journal of Obstetrics and Gynecology. 168(2): 1993; 633–637.
   Web of Science ®Google Scholar
• AM Altman, PG Stubblefield, JF Schlam. Midtrimester abortion with Laminaria and vacuum evacuation on a teaching service. Journal of Reproductive Medicine. 30(8): 1985; 601–606.
   PubMed Web of Science ®Google Scholar
• A Patel, E Talmont, J Morfesis. Adequacy and safety of buccal misoprostol for cervical preparation prior to termination of second-trimester pregnancy. Contraception. 73(4): 2006; 420–430.
   PubMed Web of Science ®Google Scholar
• LD Castleman, KT Oanh, AG Hyman. Introduction of the dilation and evacuation procedure for second-trimester abortion in Viet Nam using manual vacuum aspiration and buccal misoprostol. Contraception. 74(3): 2006; 272–276.
   PubMed Web of Science ®Google Scholar
• PD Darney, E Atkinson, K Hirabayashi. Uterine perforation during second-trimester abortion by cervical dilation and instrumental extraction: a review of 15 cases. Obstetrics and Gynecology. 75(3/Part 1): 1990; 441–444.
   Web of Science ®Google Scholar
• PD Darney, RL Sweet. Routine intraoperative ultrasonography for second trimester abortion reduces incidence of uterine perforation. Journal of Ultrasound Medicine. 8(2): 1989; 71–75.
   Web of Science ®Google Scholar
• AG Thomas, M Alvarez, F Friedman Jr. The effect of placenta previa on blood loss in second-trimester pregnancy termination. Obstetrics and Gynecology. 84(1): 1994; 58–60.
   Web of Science ®Google Scholar
• WK Rashbaum, EJ Gates, J Jones. Placenta accreta encountered during dilation and evacuation in the second trimester. Obstetrics and Gynecology. 85(5 Pt 1): 1995; 701–703.
   Web of Science ®Google Scholar
• KF Schulz, DA Grimes, DD Christensen. Vasopressin reduces blood loss from second-trimester dilatation and evacuation abortion. Lancet. 2(8451): 1985; 353–356.
   Web of Science ®Google Scholar
• GF Sawaya, D Grady, K Kerlikowske, DA Grimes. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstetrics and Gynecology. 87(5 Pt 2): 1996; 884–890.
   Web of Science ®Google Scholar
• GJ Daskalakis, SA Mesogitis, NE Papantoniou. Misoprostol for second trimester pregnancy termination in women with prior caesarean section. BJOG. 112(1): 2005; 97–99.
   Web of Science ®Google Scholar
• JE Dickinson. Misoprostol for second-trimester pregnancy termination in women with a prior cesarean delivery. Obstetrics and Gynecology. 105(2): 2005; 352–356.
   PubMed Web of Science ®Google Scholar
• C Mazouni, M Provensal, G Porcu. Termination of pregnancy in patients with previous cesarean section. Contraception. 73(3): 2006; 244–248.
   PubMed Web of Science ®Google Scholar
• H el-Refaey, A Templeton. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. Human Reproduction. 10(2): 1995; 475–478.
   PubMed Web of Science ®Google Scholar
• NB Kaltreider, S Goldsmith, AJ Margolis. The impact of midtrimester abortion techniques on patients and staff. American Journal of Obstetrics and Gynecology. 135(2): 1979; 235–238.
   PubMed Web of Science ®Google Scholar